Statistical Fragility of Findings From Randomized Phase 3 Trials in Pediatric Oncology
ABSTRACT Purpose The fragility index (FI) is an adjunctive metric to facilitate the interpretation of p‐values in clinical trials. The FI has not been studied in phase 3 trials in pediatric oncology. Methods PubMed was used to identify phase 3 pediatric oncology trials published between 1980 and 202...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-12-01
|
| Series: | Cancer Medicine |
| Online Access: | https://doi.org/10.1002/cam4.70356 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|